Dysregulated expression of FOXM1 isoforms drives progression of pancreatic cancer

Cancer Research

Volumn 73, Issue 13, 2013, Pages 3987-3996

  Kong, Xiangyu ^a,c   Li, Lei ^a   Li, Zhaoshen ^a   Le, Xiangdong ^c   Huang, Chen ^b,c   Jia, Zhiliang ^c   Cui, Jiujie ^b,c   Huang, Suyun ^c   Wang, Liwei ^b   Xie, Keping ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; KRUPPEL LIKE FACTOR 4; MESSENGER RNA; TRANSCRIPTION FACTOR FORKHEAD BOX M1A; TRANSCRIPTION FACTOR FORKHEAD BOX M1B; TRANSCRIPTION FACTOR FORKHEAD BOX M1B1; TRANSCRIPTION FACTOR FORKHEAD BOX M1B2; TRANSCRIPTION FACTOR FORKHEAD BOX M1C; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; DELETION MUTANT; EMBRYO; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; TUMOR INVASION;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84880056261     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-3859     Document Type: Article

References (45)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60: 277-300.
2. Nieto J, Grossbard ML, Kozuch P. Metastatic pancreatic cancer 2008: is the glass less empty. Oncologist 2008;13: 562-76.
3. Pliarchopoulou K, Pectasides D. Pancreatic cancer: current and future treatment strategies. Cancer Treat Rev 2009;35: 431-6.
4. Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges. Nat Rev Clin Oncol 2010;7: 163-72.
5. Clark KL, Halay ED, Lai E, Burley SK. Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature 1993;364: 412-20.
6. Kalin TV, Ustiyan V, Kalinichenko VV. Multiple faces of FOXM1 transcription factor: lessons from transgenic mouse models. Cell Cycle 2011;10: 396-405.
7. Ye H, Kelly TF, Samadani U, Lim L, Rubio S, Overdier DG, et al. Hepatocyte nuclear factor 3/fork head homolog 11 is expressed in proliferating epithelial and mesenchymal cells of embryonic and adult tissues. Mol Cell Biol 1997;17: 1626-41.
8. Korver W, Roose J, Clevers H. The winged-helix transcription factor Trident is expressed in cycling cells. Nucleic Acids Res 1997;25: 1715-9.
9. Raychaudhuri P, Park HJ. FOXM1: a master regulator of tumor metastasis. Cancer Res 2011;71: 4329-33.
10. Koo CY, Muir KW, Lam EW. FOXM1: from cancer initiation to progression and treatment. Biochim Biophys Acta 2012;1819: 28-37.
11. Kim IM, Ackerson T, Ramakrishna S, Tretiakova M, Wang IC, Kalin TV, et al. The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer. Cancer Res 2006;66: 2153-61.
12. Chan DW, Yu SY, Chiu PM, Yao KM, Liu VW, Cheung AN, et al. Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis. J Pathol 2008;215: 245-52.
13. Li Q, Zhang N, Jia Z, Le X, Dai B, Wei D, et al. Critical role and regulation of transcription factor FOXM1 in human gastric cancer angiogenesis and progression. Cancer Res 2009;69: 3501-9.
14. Liu M, Dai B, Kang SH, Ban K, Huang FJ, Lang FF, et al. FOXM1B is overexpressed in human glioblastomas and critically regulates the tumorigenicity of glioma cells. Cancer Res 2006;66: 3593-602.
15. Priller M, Poschl J, Abrao L, von Bueren AO, Cho YJ, Rutkowski S, et al. Expression of FOXM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients. Clin Cancer Res 2011;17: 6791-801.
16. Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH. Down-regulation of Forkhead BoxM1transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 2007;67: 8293-300.
17. Bao B, Wang Z, Ali S, Kong D, Banerjee S, Ahmad A, et al. Overexpression of FOXM1 leads to epithelial-mesenchymal transition and cancer stem cell phenotype in pancreatic cancer cells. J Cell Biochem 2011;112: 2296-306.
18. Huang C, Qiu Z, Wang L, Peng Z, Jia Z, Logsdon CD, et al. A novel FOXM1-Caveolin signaling pathway promotes pancreatic cancer invasion and metastasis. Cancer Res 2012;72: 655-65.
19. Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem 1996;271: 20009-17.
20. McConnell BB, Ghaleb AM, Nandan MO, Yang VW. The diverse functions of Kruppel-like factors 4 and 5 in epithelial biology and pathobiology. Bioessays 2007;29: 549-57.
21. Wei D, Gong W, Kanai M, Schlunk C, Wang L, Yao JC, et al. Drastic down-regulation of Kruppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res 2005;65: 2746-54.
22. Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, Yang VW, et al. The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 2002;129: 2619-28.
23. Morgan RT, Woods LK, Moore GE, Quinn LA,McGavran L, Gordon SG. Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma. Int J Cancer 1980;25: 591-8.
24. Vezeridis MP, Tzanakakis GN, Meitner PA, Doremus CM, Tibbetts LM, Calabresi P. In vivo selection of a highly metastatic cell line of a human pancreatic carcinoma in the nude mouse. Cancer 1992;69: 2060-3.
25. Wang B, Wei D, Crum VE, Richardson EL, Xiong HH, Luo Y, et al. A novel model system for studying the double-edged roles of nitric oxide production in pancreatic cancer growth and metastasis. Oncogene 2003;22: 1771-82.
26. Wang L, Wei D, Huang S, Peng Z, Le X, Wu TT, et al. Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer. Clin Cancer Res 2003;9: 6371-80.
27. Marvin MR, Southall JC, Trokhan S, DeRosa C, Chabot J. Liver metastases are enhanced in homozygous deletionally mutant ICAM-1 or LFA-1 mice. J Surg Res 1998;80: 143-8.
28. Zhang Y, Zhang N, Dai B, Liu M, Sawaya R, Xie K, et al. FOXM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells. Cancer Res 2008;68: 8733-42.
29. Wei D, Kanai M, Jia Z, Le X, Xie K. Kruppel-like factor 4 induces p27Kip1 expression in and suppresses the growth and metastasis of human pancreatic cancer cells. Cancer Res 2008;68: 4631-9.
30. Wei D, Wang L, Kanai M, Jia Z, Le X, Li Q, et al. KLF4alpha upregulation promotes cell cycle progression and reduces survival time of patients with pancreatic cancer. Gastroenterology 2010;139: 2135-45.
31. Dai B, Kang SH, Gong W, Liu M, Aldape KD, Sawaya R, et al. Aberrant FOXM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells. Oncogene 2007;26: 6212-9.
32. Wierstra I, Alves J. FOXM1, a typical proliferation-associated transcription factor. Biol Chem 2007;388: 1257-74.
33. Wang Z, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. Forkhead box M1 transcription factor: a novel target for cancer therapy. Cancer Treat Rev 2010;36: 151-6.
34. Laoukili J, Stahl M, Medema RH. FOXM1: at the crossroads of ageing and cancer. Biochim Biophys Acta 2007;1775: 92-102.
35. Wierstra I, Alves J. FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3alpha. Biochem Biophys Res Commun 2006;348: 99-108.
36. Wierstra I. The transcription factor FOXM1c is activated by protein kinase CK2, protein kinase A (PKA), c-Src and Raf-1. Biochem Biophys Res Commun 2011;413: 230-5.
37. Wierstra I, Alves J. FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2. FEBS J 2006;273: 4645-67.
38. Park HJ, Costa RH, Lau LF, Tyner AL, Raychaudhuri P. Anaphasepromoting complex/cyclosome-CDH1-mediated proteolysis of the forkhead box M1 transcription factor is critical for regulated entry into S phase. Mol Cell Biol 2008;28: 5162-71.
39. Gieling RG, Elsharkawy AM, Caamaño JH, Cowie DE, Wright MC, Ebrahimkhani MR, et al. The c-Rel subunit of nuclear factor-kappaB regulates murine liver inflammation, wound-healing, and hepatocyte proliferation. Hepatology 2010;51: 922-31.
40. Kalinichenko VV, Major ML, Wang X, Petrovic V, Kuechle J, Yoder HM, et al. FOXM1b transcription factor is essential for development of hepatocellular carcinomas and is negatively regulated by the p19ARF tumor suppressor. Genes Dev 2004;18: 830-50.
41. Fu Z, Malureanu L, Huang J, Wang W, Li H, van Deursen JM, et al. Plk1- dependent phosphorylation of FOXM1 regulates a transcriptional programme required for mitotic progression. Nat Cell Biol 2008;10: 1076-82.
42. Huang C, Xie K. Crosstalk of Sp1 and Stat3 signaling in pancreatic cancer pathogenesis. Cytokine Growth Factor Rev 2012;23: 25-35.
43. Gao Y, Jia Z, Kong X, Li Q, Chang DZ, Wei D, et al. Combining betulinic acid and mithramycin a effectively suppresses pancreatic cancer by inhibiting proliferation, invasion, and angiogenesis. Cancer Res 2011;71: 5182-93.
44. Jiang NY, Woda BA, Banner BF, Whalen GF, Dresser KA, Lu D. Sp1, a new biomarker that identifies a subset of aggressive pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2008;17: 1648-52.
45. Xie K, Wei D, Huang S. Transcriptional anti-angiogenesis therapy of human pancreatic cancer. Cytokine Growth Factor Rev 2006;17: 147-56.